Literature DB >> 16367887

Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome.

G T-C Ko1, W-Y So, N N Chan, W-B Chan, P C-Y Tong, J Li, V Yeung, C-C Chow, R Ozaki, R C-W Ma, C S Cockram, J C-N Chan.   

Abstract

AIM: The aim of this study is to investigate the prevalence of metabolic syndrome (MES) in type 2 diabetic patients and the predictive values of the World Health Organization (WHO) and National Cholesterol Education Programme (NCEP) definitions and the individual components of the MES on total and cardiovascular mortality.
METHODS: A prospective analysis of a consecutive cohort of 5202 Chinese type 2 diabetic patients recruited between July 1994 and April 2001.
RESULTS: The prevalence of the MES was 49.2-58.1% depending on the use of various criteria. There were 189 deaths (men: 100 and women: 89) in these 5205 patients during a median (interquartile range) follow-up period of 2.1 (0.3-3.6 years). Of these, 164 (87%) were classified as cardiovascular deaths. Using the NCEP criterion, patients with MES had a death rate similar to those without (3.51 vs. 3.85%). By contrast, based on the WHO criteria, patients with MES had a higher mortality rate than those without (4.3 vs. 2.4%, p = 0.002). Compared to patients with neither NCEP- nor WHO-defined MES, only the group with MES defined by the WHO, but not NCEP, criterion had significantly higher mortality rate (2.6 vs. 6.8%, p < 0.001). Using Cox regression analysis, only age, duration of diabetes and smoking were identified as independent factors for cardiovascular or total death. Among the various components of MES, hypertension, low BMI and albuminuria were the key predictors for these adverse events.
CONCLUSIONS: In Chinese type 2 diabetic patients, the WHO criterion has a better discriminative power over the NCEP criterion for predicting death. Among the various components of the MES defined either by WHO or NCEP, hypertension, albuminuria and low BMI were the main predictors of cardiovascular and total mortality.

Entities:  

Mesh:

Year:  2006        PMID: 16367887     DOI: 10.1111/j.1463-1326.2005.00475.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  8 in total

1.  Cardiovascular Disease Risk Assessment: Review of Established and Newer Modalities.

Authors:  David M Tehrani; Nathan D Wong
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-12

Review 2.  Impact of microalbuminuria on incident coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis of prospective studies.

Authors:  Fang Xia; Guanghua Liu; Yifu Shi; Yan Zhang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 3.  Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.

Authors:  Szu-chi Chen; Chin-Hsiao Tseng
Journal:  Rev Diabet Stud       Date:  2013-08-10

4.  Usefulness of microalbuminuria versus the metabolic syndrome as a predictor of cardiovascular disease in women and men>40 years of age (from the Rancho Bernardo Study).

Authors:  Simerjot Kaur Jassal; Claudia Langenberg; Denise von Mühlen; Jaclyn Bergstrom; Elizabeth Barrett-Connor
Journal:  Am J Cardiol       Date:  2008-03-07       Impact factor: 2.778

Review 5.  The Obesity Paradox in Type 2 Diabetes and Mortality.

Authors:  Deirdre K Tobias; JoAnn E Manson
Journal:  Am J Lifestyle Med       Date:  2016-05-19

6.  Metabolic syndrome in peritoneal dialysis patients.

Authors:  Philip Kam-Tao Li; Bonnie Ching-Ha Kwan; Cheuk Chun Szeto; Gary Tin-Choi Ko
Journal:  NDT Plus       Date:  2008-06-27

7.  The Association between Metabolic Syndrome and Morbid Events in Type 2 Diabetes after a 7-Year Community Management: Beijing Community Diabetes Study 17.

Authors:  Guang-Ran Yang; Ming-Xia Yuan; Han-Jing Fu; Gang Wan; Dongmei Li; Timothy D Dye; Liang-Xiang Zhu; Rong-Rong Xie; Yu-Jie Lv; Jian-Dong Zhang; Xue-Ping Du; Yu-Ling Li; Yu Ji; Yue Li; Xue-Li Cui; Zi-Ming Wang; Shu-Yan Cheng; De-Yuan Liu; Qian Wang; Li Zhou; Ying Gao; Shen-Yuan Yuan
Journal:  J Diabetes Res       Date:  2019-06-12       Impact factor: 4.011

8.  Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients - the Hong Kong diabetes registry.

Authors:  Xilin Yang; Ronald C Ma; Wing-Yee So; Gary T Ko; Alice P Kong; Christopher W Lam; Chun-Shun Ho; Clive S Cockram; Vivian C Wong; Peter C Tong; Juliana C Chan
Journal:  Cardiovasc Diabetol       Date:  2007-12-02       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.